Parteck® SRP 80 by The Life Science business of Merck KGaA, Darmstadt, Germany, operates as MilliporeSigma in the U.S. and Canada

4.7
/
5.0
  |  1 reviews
Parteck® SRP 80, a functional excipient based on polyvinyl alcohol (PVA), provides reliable sustained drug delivery over long release periods. Its matrix diffusion technology helps increase the efficacy and bioavailability of your compound while reducing side effects and the risk of dose dumping. Parteck® SRP 80 is well suited for direct compression processes and helps accelerate your formulation work—from simplified feasibility and development to rapid and cost-effici... Read more


Parteck® SRP 80 by The Life Science business of Merck KGaA, Darmstadt, Germany, operates as MilliporeSigma in the U.S. and Canada product image
Parteck® SRP 80
Request Pricing

Receive your quote directly from the manufacturer.




Average Rating: 4.7
1 Scientist has reviewed this product

5 out of 5
Ease of use
5 out of 5
After sales service
4 out of 5
Value for money


  • Status:

    Reviewer
  • Member since: 2016

  • Organization: CONTINUUS Pharmaceuticals



  • Ease of use
    5 out of 5
    After sales service
    5 out of 5
    Value for money
    4 out of 5
Share this Review on LinkedinShare this Review on TwitterShare this Review on Facebook
Great excipient for sustained release formulations
Rating: 4.7

  • Application Area: Pharmaceutical formulations

"We've been testing this excipient in sustained release oral formulations and it seems to work very well. More importantly, it is compatible with a broad range of active pharmaceutical ingredients [salts, acids, bases and neutral species]. It comes with a very thorough C of A and Millipore's technical support has been OUTSTANDING!"

Review date: 01 Aug 2017 | Parteck® SRP 80

Parteck® SRP 80, a functional excipient based on polyvinyl alcohol (PVA), provides reliable sustained drug delivery over long release periods. Its matrix diffusion technology helps increase the efficacy and bioavailability of your compound while reducing side effects and the risk of dose dumping.

Parteck® SRP 80 is well suited for direct compression processes and helps accelerate your formulation work—from simplified feasibility and development to rapid and cost-efficient manufacturing.

Benefits of Parteck® SRP 80:

  • Reliable sustained release profiles of active pharmaceutical ingredients over several hours
  • Suitable for direct compression processes with conventional equipment
  • Resistant to pH- and alcohol-induced dose dumping
  • Superior batch-to-batch consistency and robust performance due to fully synthetic material
  • Faster time to market with the Emprove® program